one-hundred and eighteen patients with rheumatoid arthritis were treated for 4 weeks with flurbiprofen 300 mg/day ( sixty patients ) or naproxen 750 mg/day ( fifty-eight patients ) in a six-centre randomized trial .
C0003873
rheumatoid arthritis
C0016377
flurbiprofen